Rob E. Aarnoutse

11.0k citations
237 papers · 8.7k · 2 hit papers · h-index 51

Impact in

    • Tuberculosis Research and Epidemiology
    • HIV/AIDS drug development and treatment
  • Pharmacology top 0.2%
    • Antibiotics Pharmacokinetics and Efficacy
    • Drug-Induced Hepatotoxicity and Protection

Papers in

    • Tuberculosis Research and Epidemiology 91
    • HIV/AIDS drug development and treatment 32
    • HIV/AIDS Research and Interventions 13
    • Pneumocystis jirovecii pneumonia detection and treatment 32
    • Mycobacterium research and diagnosis 23

Rob E. Aarnoutse

229 papers receiving 8.4k citations

Rob E. Aarnoutse's Hit Papers

Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children 2022 · 125 citations
1250+6+12Years since publication200400600

Peers

Rob E. Aarnoutse
Comparison fields: 5 of 141
  • Infectious Diseases 5.2k
  • Pharmacology 740
  • Epidemiology 2.7k
  • Virology 372
  • Pharmacology 931
Replace William J. Burman with:
William J. Burman United States
Giovanni Di Perri Italy
Helen McIlleron South Africa
Antonio D'Avolio Italy
Michael Noel Neely United States
Jan‐Willem C. Alffenaar Netherlands
David Marinus Burger Netherlands
Charles A. Peloquin United States
Kelly E. Dooley United States
Michel Tod France
Rob E. Aarnoutse relative to William J. Burman United States William J. Burman's profile →
Citations per field
00.5×2×4×5.8×
William J. Burman · 1×
Citations per year

Countries citing papers authored by Rob E. Aarnoutse

Since Specialization
Citations

This map shows the geographic impact of Rob E. Aarnoutse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob E. Aarnoutse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob E. Aarnoutse more than expected).

Fields of papers citing papers by Rob E. Aarnoutse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob E. Aarnoutse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob E. Aarnoutse. The network helps show where Rob E. Aarnoutse may publish in the future.

Co-authors

The 25 scholars most cited alongside Rob E. Aarnoutse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rob E. Aarnoutse Line = papers co-authored together Rob E. Aarnoutse links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 237 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review
Hit paper breakdown →
2007618
2 2016312
3 2012301
4 2015260
5 2008218
6 2006192
7 2010186
8 2012177
9 2014163
10 2007160
11 2007146
12 2003142
13 2003131
14
Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children
Hit paper breakdown →
2022125
15 2008113
16 2009100
17 201799
18 201692
19 200989
20 201889

About Rob E. Aarnoutse

Rob E. Aarnoutse is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Pediatrics, Perinatology and Child Health and Virology, having authored 237 papers that have together received 8.7k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (91 papers), Pneumocystis jirovecii pneumonia detection and treatment (32 papers), HIV/AIDS drug development and treatment (32 papers), Antibiotics Pharmacokinetics and Efficacy (29 papers), Infectious Diseases and Tuberculosis (25 papers), Mycobacterium research and diagnosis (23 papers), Drug Transport and Resistance Mechanisms (16 papers) and HIV/AIDS Research and Interventions (13 papers). The work is most often cited by research in Infectious Diseases (5.2k citations), Pharmacology (740 citations), Epidemiology (2.7k citations), Virology (372 citations) and Pharmacology (931 citations). Rob E. Aarnoutse has collaborated with scholars based in Netherlands, United States and South Africa. Frequent co-authors include Martin Johan Boeree, David Marinus Burger, Reinout van Crevel, Rovina Ruslami, André J. A. M. van der Ven, Bachti Alisjahbana, Alma Tostmann, Gibson Sammy Kibiki, Roger J. M. Brüggemann and Wiel C.M. de Lange. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents, Clinical Infectious Diseases and Therapeutic Drug Monitoring.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact